Pharmaceutical Commerce - June 2022

Click the title above for a link to open the Pharmaceutical Commerce June 2022 issue in an interactive PDF format.

A reflection on the industry's effort to foster and facilitate sustainability

A conversation with EY life sciences leaders Jim Welch and Jay Welsh

Proper control of type 1 and 2 diabetes can greatly reduce the personal impact and economic burden of this pervasive public health condition. To that end, stakeholders are exploring many parallel routes to help individuals and society maintain the upper hand, as the toll of diabetes continues to skyrocket

Pharma supply chain management will be one of the earliest beneficiaries of the Fourth Industrial Revolution, and the potential of ‘networks of networks’

Why ‘real-time-all-the-time’ supply chain operations are fundamental to biopharma success

The packaging and shipping of dangerous goods (DG) adds further challenges to the distribution pressures brought about by the pandemic

The clock is ticking on a massive effort to bring interoperable, electronic tracking of pharma shipments in the US

A recommended checklist for manufacturers as they enlist distributor and 3PL support—and the important questions they should be asking themselves

Pressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance

Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials

The crucial link of labeling and packaging in the pharma supply chain has its glory, but is not without its set of obstacles amid current market and global challenges

The clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials

Outlining the core functional skill sets of the most effective hub programs—all toward the goal of helping patients get on prescriptions as quickly as possible

How CDMOs will lead the way toward true cloud lab enablement